Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Taylor P Berke, Simon H Slight & Salman M Hyder. (2022) Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer. OncoTargets and Therapy 15, pages 23-30.
Read now
Read now
Ahmad Kazemi, Majid Safa & Atefeh Shahbazi. (2011) RITA enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis. Hematology 16:4, pages 225-231.
Read now
Read now
Articles from other publishers (10)
Xiaoyong Ge, Hui Xu, Siyuan Weng, Yuyuan Zhang, Long Liu, Libo Wang, Zhe Xing, Yuhao Ba, Shutong Liu, Lifeng Li, Yuhui Wang & Xinwei Han. (2023) Systematic analysis of transcriptome signature for improving outcomes in lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology 149:11, pages 8951-8968.
Crossref
Crossref
Qing Ye, Rebecca A. Raese, Dajie Luo, Juan Feng, Wenjun Xin, Chunlin Dong, Yong Qian & Nancy Lan Guo. (2023) MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer. Cells 12:14, pages 1917.
Crossref
Crossref
Rita Nahta & Robert Craig Castellino. (2021) Phosphatase magnesium-dependent 1 δ (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer. Biochemical Pharmacology 184, pages 114362.
Crossref
Crossref
Avinash Kumar, Ekta Rathi, Raghu Chandrashekar Hariharapura & Suvarna G. Kini. (2020) Is viral E6 oncoprotein a viable target? A critical analysis in the context of cervical cancer. Medicinal Research Reviews 40:5, pages 2019-2048.
Crossref
Crossref
Brian D. Peyser, Ann Hermone, Joseph M. Salamoun, James C. Burnett, Melinda G. Hollingshead, Connor F. McGrath, Rick Gussio & Peter Wipf. (2019)
Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining
In Vivo
Antitumor Efficacy
. Molecular Cancer Therapeutics 18:10, pages 1765-1774.
Crossref
Crossref
Leonid V. Romashov & Valentine P. Ananikov. (2017) Alkynylation of Bio-Based 5-Hydroxymethylfurfural to Connect Biomass Processing with Conjugated Polymers and Furanic Pharmaceuticals. Chemistry - An Asian Journal 12:20, pages 2652-2655.
Crossref
Crossref
S. Emami. (2011) Interplay between p53-family, their regulators, and PARPs in DNA repair. Clinics and Research in Hepatology and Gastroenterology 35:2, pages 98-104.
Crossref
Crossref
Manujendra N. Saha, Hua Jiang, Asuka Mukai & Hong Chang. (2010) RITA Inhibits Multiple Myeloma Cell Growth through Induction of p53-Mediated Caspase-Dependent Apoptosis and Synergistically Enhances Nutlin-Induced Cytotoxic Responses. Molecular Cancer Therapeutics 9:11, pages 3041-3051.
Crossref
Crossref
Aldo AndreaniSilvia BurnelliMassimiliano GranaiolaAlberto LeoniAlessandra LocatelliRita MorigiMirella RambaldiLucilla VaroliLaura LandiCecilia PrataMichael V. BerridgeCarole GrassoHeinz-Herbert FiebigGerhard KelterAngelika M. BurgerMark W. Kunkel. (2008) Antitumor Activity of Bis-indole Derivatives. Journal of Medicinal Chemistry 51:15, pages 4563-4570.
Crossref
Crossref
Gretchen A. LaRusch, Mark W. Jackson, James D. Dunbar, Robert S. Warren, David B. Donner & Lindsey D. Mayo. (2007) Nutlin3 Blocks Vascular Endothelial Growth Factor Induction by Preventing the Interaction between Hypoxia Inducible Factor 1α and Hdm2. Cancer Research 67:2, pages 450-454.
Crossref
Crossref